| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | United States | 3 | |
| #3 | Taiwan | 2 | |
| #4 | Australia | 1 | |
| #5 | Canada | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Organic chemistry methods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Yan Shunqi | 14 |
| #2 | Orr Robert | 9 |
| #3 | Yeh Li-Tain | 8 |
| #4 | Yeh Litain | 5 |
| #5 | Yan Rongzi | 3 |
| #6 | Li Zheng Jane | 2 |
| #7 | Wang Rui-Ping | 1 |
| #8 | Yeh Li Tain | 1 |
| #9 | Shen Zancong | 1 |
| #10 | Wang Ruiping | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020232156A1 | Compound for treating gout or hyperuricemia | |
| WO2020118113A1 | Crystalline forms of a compound for treating or preventing gout or hyperuricemia | |
| WO2020118114A1 | Methods for treating or preventing gout or hyperuricemia | |
| EP3484862A1 | Compounds, compositions and methods for treating or preventing a sympton associated with gout or hyperuricemia |